Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betamethasone dipropionate + salicylic acid ointment versus Diprosalic versus vehicle in chronic stable plaque psoriasis
2020-004081-19Phase 3Active
- Sponsor
- Dermapharm
- Start
- Aug 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of betamethasone dipropionate and Salvax in plaque psoriasis (3 arms), sponsored by Dermapharm. Primary endpoint: Percent change in modified Psoriasis Area and Severity Index. Started Aug 2021; status: active.
02
Drugs
betamethasone dipropionateSalvax
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2020-004081-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004081-19.